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ABSTRACT  
 
Bilirubin is an endogenous antioxidant with cytoprotective properties, and several 
studies highlight its potential in the treatment of pro-oxidant diseases. We demonstrated 
that oxidative stress (OS), a key feature in most hepatopathies, induces cholestasis by 
actin cytoskeleton disarrangement and further endocytic internalization of key 
canalicular transporters, such as the bile salt export pump (Bsep) and the multidrug 
resistance-associated protein 2 (Mrp2). Here, we evaluated the capability of 
physiological concentrations of unconjugated bilirubin (UB) to limit OS and the 
impairment in biliary secretory function induced by the model pro-oxidant agent, tert-
butylhydroperoxide (tBuOOH). UB fully prevented the formation of reactive oxygen 
species (ROS) and membrane lipid peroxidation induced by tBuOOH in isolated rat 
hepatocytes. In the isolated rat hepatocyte couplet model, UB (17.1 µM) prevented the 
endocytic internalization of Bsep and Mrp2 and the impairment in their secretory 
function induced by tBuOOH. UB also prevented actin disarrangement, as evaluated by 
both plasma membrane bleb formation and actin fluorescent staining. Finally, UB 
prevented tBuOOH-induced cPKC activation. Experiments in isolated perfused rat 
livers showed that UB prevents the increase in oxidized glutathione biliary excretion 
and the drop in bile flow and the biliary excretion of specific Bsep and Mrp2 substrates. 
We conclude that physiological concentrations of UB are sufficient to prevent the 
biliary secretory failure induced by OS, by counteracting actin disarrangement and the 
consequent internalization of canalicular transporters relevant to normal bile formation. 
This reveals an important role for UB in preserving biliary secretory function under OS 
conditions. 
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INTRODUCTION 
Due to its multiple energy-dependent functions, liver has a high mitochondrial 
metabolic rate, and is heavily engaged in detoxification mechanisms that involve redox-
enzyme systems. Since these are major sources of endogenous free radicals, reactive 
oxygen species (ROS) production is higher in liver as compared with most organs. To 
counterbalance this oxidative challenge, hepatocytes are equipped with abundant 
antioxidant defenses that are critical to cellular integrity, including reduced glutathione 
and the redox enzymes catalase, glutathione peroxidase, and superoxide 
dismutase(Cessaratto et al. 2004). This borderline equilibrium makes liver highly 
susceptible to the pro-oxidant injury induced by pathological conditions that disrupt this 
balance by either or both increments in ROS formation and impairment of antioxidant 
defenses. Indeed, oxidative stress (OS) is a common feature in most hepatopathies, 
including, among others, hepatic ischemia-reperfusion injury following hepatectomy or 
liver transplantation, obstructive cholestasis, chronic cholestatic liver diseases, sepsis-
induced cholestasis, viral, toxic, and autoimmune hepatitis, alcoholic and non-alcoholic 
steatohepatitis, and pathologies leading to hepatic accumulation of heavy metals, such 
as iron (hemochromatosis, iron-loading anemia) or copper (Wilson´s disease) 
(Cessaratto et al. 2004, Copple et al. 2010). 
In recent years, evidence has accumulated that OS is cholestatic in nature (Roma 
and Sanchez Pozzi 2008). Schmitt et al.(2000) and Kawai et al. (2007) observed a rapid 
decrease in bile flow, resulting in a complete cholestasis, after 60 min of perfusion of rat 
livers with 500 µM of the pro-oxidant agent tert-butylhydroperoxide (tBuOOH). By 
using isolated rat hepatocyte couplets, an in vitro, polarized model to study 
hepatocanalicular secretory function, our group demonstrated that endocytic 
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internalization of canalicular transporters is a key factor in this phenomenon. We have 
previously shown in isolated hepatocyte couplets that tBuOOH induces endocytic 
internalization of the bile salt export pump (Bsep), a main canalicular transporter that 
transports osmotically active monoanionic bile salts into the bile canaliculus, the main 
driving forces involved in the generation of the so called bile-salt independent bile flow 
(Pérez et al. 2006a). The same holds true for multidrug resistance-associated protein 2 
(Mrp2), as has been shown in hepatocytes exposed to the pro-oxidant agents tBuOOH 
(Schmitt et al. 2000) and chloro-dinitro benzene (Schmitt et al. 2000); this transporter 
apically exports oxidized (GSSG) and reduced (GSH) glutathione (Yang et al. 2001), 
the main driving forces for the so called bile-salt-independent bile flow (Ballatori and 
Truong 1992). Previous studies from our laboratory in isolated rat hepatocyte couplets 
demonstrated that the mechanism underlying the internalization of canalicular 
transporters under OS conditions involves actin cytoskeleton disarrangement. Actin 
redistributes from pericanalicular zone to the rest of cell body, with the consequent 
formation of plasma membrane blebs (Pérez et al. 2006a). This phenomenon is 
triggered by a dysregulation of intracellular calcium levels, and the consequent 
activation of calcium-dependent protein kinase C (cPKC) (Pérez et al. 2006a,b). The 
extent to which these in vitro studies reproduce the actual situation in vivo is limited 
though, since cells are exposed to an extracellular medium lacking important cholephilic 
endogenous compounds, such as bile salts and bilirubin, which may have regulatory and 
even protective effects on the hepatocyte. 
Bilirubin is the end product of heme degradation in mammals.By the concerted 
action of the enzymes heme oxygenase 1 and biliverdin reductase, heme molecule is 
degraded into iron, carbon monoxide, and biliverdin, which is subsequently converted 
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into bilirubin (Maines 1997). Once formed, unconjugated bilirubin (UB) is carried in 
blood in the form of a reversible complex with serum albumin (McDonagh 2010). In 
liver, UB is converted into a series of water soluble derivatives by conjugation of one or 
two of its propionyl groups with glucuronic acid, glucose or xylose (Fevery 1977), 
before being excreted into bile, via Mrp2 (Nies 2007). 
Although long considered a toxic waste product of heme catabolism, bilirubin 
has emerged as an important protective molecule in circulation. Previous in vitro studies 
demonstrated that bilirubin is an efficient antioxidant under physiological conditions 
(Stocker et al. 1987a, Sedlak et al. 2009). The antioxidant effects of bilirubin in vivo 
include scavenging of peroxyl radicals (Witting et al. 1996), inhibition of membrane 
lipid peroxidation (Witting et al. 1996), and scavenging of radical nitrogen species 
(Kaur et al. 2003). Albumin-bound bilirubin, in its unconjugated form, bears an 
extended system of conjugated double bonds and a pair of reactive hydrogen atoms 
which are most likely involved in bilirubin antioxidant action, by hydrogen donation to 
a radical species (Stocker 2004). Notably, binding of UB to albumin increases its radical 
scavenging action, in a reaction by which UB is stoichiometrically converted into its 
metabolic precursor, biliverdin (Stocker et al. 1987b). It is known that bilirubin greatly 
contributes to antioxidant defenses, due to its potent and versatile antioxidant activity. 
Moreover, several studies put forward the potential of UB in the treatment of 
cardiovascular (Ryter et al. 2007) and pulmonary (Ryter et al. 2007) diseases, as well as 
in the post-transplantation ischemia-reperfusion injury (Ollinger et al. 2007) and the 
immune response (Morita et al. 2003).These assumptions regarding the beneficial 
effects of bilirubin have been confirmed and extended by our previous studies on the 
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hepatoprotective effects of UB on complement system-mediated cell lysis (Arriaga et al. 
2009, Basiglio et al.2007 and 2010). 
Bearing in mind the well-established antioxidant effects of UB, we hypothesize 
that UB may have a protective role against OS-induced cholestasis. Our results show 
that, even at physiological concentrations, UB has striking protective effects against 
OS-induced bile secretory failure, as assessed both in isolated rat hepatocyte couplets 
(IRHC) and in the isolated perfused rat liver (IPRL). 
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MATERIALS AND METHODS 
Materials.Collagenase type A (from Clostridiumhistolyticum),bovine serum albumin 
(BSA) fraction V,UB (predominantly IXα isomer), tBuOOH, thiobarbituric acid (TBA), 
dichlorofluorescein-diacetate (DCF-DA), taurocholate and chloro-dinitro benzene 
(CDNB) were purchased from Sigma Chemical Co. (St. Louis, MO, USA). 5-
chloromethyl-fluorescein-diacetate (CMF-DA) and Alexa Fluor 568 phalloidin were 
obtained from Molecular Probes (Eugene, OR, USA). Rabbit anti-rat Bsep was from 
Kamiya Biomedical Co. (Seattle, WA, USA) and mouse anti-human MRP2 (M2III-6) 
was from Alexis Biochemicals (San Diego, CA, USA). Cy2-conjugated donkey anti-
rabbit IgG (31458) and Cy2-conjugated goat anti-mouse IgG (31430) were obtained 
from Thermo Fisher Scientific, Inc. (Waltham, MA, USA). Cholyl-glycylamido-
fluorescein (CGamF) was a generous gift from Prof. Alan Hofmann (University of 
California, San Diego, USA). All the other chemicals were of the highest purity 
commercially available.  
Animals. Adult male Wistar rats weighing 300-350 g were used throughout. Animals 
were maintained on a standard diet and water ad libitum, and housed in a temperature- 
and humidity-controlled room under a constant 12-hour light, 12-hour dark cycle. All 
animals received humane care according to the criteria outlined in the “Guide for the 
Care and Use of Laboratory Animals”, written by the National Academy of Sciences 
and published by the National Institutes of Health (NIH publication 25-28, revised 
1996). 
Evaluation of tBuOOH-induced OS. Hepatocytes were isolated from livers by the 
collagenase perfusion technique, using the method of Berry and Friend (Berry and 
Friend 1969), with minor modifications. The resulting preparation yielded ~ 400-
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600x10
6 
hepatocytes per liver with high viability (>90%), as assessed by the Trypan 
blue exclusion test (Baur et al. 1975). 
 The magnitude of OS induced by tBuOOH was evaluated both by measuring the 
generation of the lipid peroxidation product MDA and by assessing fluorimetrically 
intracellular ROS production.  
MDA was measured by reaction with thiobarbituric acid, as described previously 
(Borgognone et al. 2005), followed by fluorimetrical HPLC detection of the MDA-
thiobarbituric acid adduct formed, according to the HPLC method of Fukunaga et al. 
(Fukunaga et al. 1993). To identify the optimal UB concentration for further studying its 
antioxidant potential, an UB concentration range from 1.7 to 85 µM was tested. 
ROS formation in isolated rat hepatocytes was assessed by using 2´,7´-
dichlorofluorescein (DCFH) as a fluorophore; its non-fluorescent, parent compound, 
2´,7´-dichlorofluorescin diacetate (DCF-DA), readily crosses the hepatocyte membrane 
and is metabolized by nonspecific esterases and oxidized to DCFH by intracellular ROS 
(Cathcart et al. 1983). DCFH was detected by flow cytometric analysis. For this 
purpose, 2x10
6
-hepatocyte suspensions were preloaded with 5 µM DCF-DA for 30 min, 
washed twice, and resuspended in the incubation medium containing UB (17.1 µM, in 
the presence of 3% BSA) or its vehicle for 15 min. We monitored the fluorescence base 
line for 2 min, and then tBuOOH was added to the medium to reach a final 
concentration of 100 µM. After that, we continued the fluorimetric detection for another 
15-min period. 
 
Studies in IRHC. 
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Couplets isolation, culture and treatments. IRHC were obtained according to the two-
step collagenase perfusion procedure followed by centrifugal elutriation as described by 
Wilton et al (1991). The resulting preparation, containing 71 ± 3% of couplets of high 
viability (>97%), was incubated in Leibovitz-15 medium at 37ºC for 4.5 h to allow for 
attachment and repolarization. After that, IRHC were incubated with UB (17.1 µM, 15 
min) in the presence of 3% BSA, and then treated with tBuOOH (100 µM, 15 min).  
Assessment of biliary secretory function.Bsep and Mrp2 transport functions were 
evaluated by using the fluorescent bile salt analog CGamF(Maglova et al. 1995)and 
glutathione methylfluorescein (GS-MF), respectively; GS-MF is a fluorescent Mrp2 
substrate derived from CMF-DA which diffuses passively, and is intracellularly 
metabolized by esterases and glutathione S-transferases(Roelofsen et al. 1998). For this 
purpose, cells were exposed to 0.3 µM CGamF (Maglova et al. 1995) or 2.5 µM CMF-
DA (Roma et al. 2000) for 15 min; after that, images were captured using a digital 
camera (Q-color5; Olympus America, Center Valley, PA, USA) under a fluorescence 
microscope (Zeiss Axiovert 25; Carl Zeiss LLC, Thornwood, NY, USA), and the 
hepatocanalicular secretory function was assessed by determining the proportion of 
IRHC (>200 per preparation) accumulating the fluorescent compounds in their 
canalicular vacuoles, as described (Roma et al. 2000). 
Assessment of actin cytoskeleton integrity. Bleb formation is a preliminary marker of 
actin cytoskeleton disruption (Gores et al. 1990). IRHC were focused under visible 
light, and blebbing was expressed as the percentage of IRHC exhibiting at least one bleb 
in either of the cells, referred to the total number of IRHC analyzed (Stone et al. 1994). 
Assessment of Bsep, Mrp2 and F-actin localization.Intracellular localization of Bsep, 
Mrp2 and actin was evaluated by confocal laser microscopy. 
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For Bsep and Mrp2 immunostaining, cells were then incubated with anti-Bsep rabbit 
antibody (1:100) or with anti-Mrp2 mouse antibody (1:100) for 2 h, followed by a 
further incubation with Cy2-labeled anti-rabbit (or anti-mouse) IgG donkey (or goat) 
antibody (1:200), for 40 min. In another set of experiments, fluorescent labeling with 
Alexa Fluor 568 phalloidinof fixed, permeabilized cells was employed to visualize 
cellular distribution of F-actin cytoskeleton. 
Once stained, the specimens for Bsep, Mrp2 and F-actin analysis were examined 
by confocal microscopy (Eclipse C1 Plus confocal microscope system; Nikon 
instruments Inc., Melville, NY, USA) and the images thus obtained were analyzed to 
quantify the total intensity of fluorescence within the couplet and, specifically, in the 
canalicular region (for Bsep and Mrp2) or in the pericanalicular region (for F-actin) 
(Crocenzi et al. 2003).  
Studies in IPRL. 
Isolated rat liver perfusion. Rat livers were perfused in situ in a non-recirculating 
system with Ringer buffer equilibrated with 5%/95% (v/v) CO2/O2. The perfusion flow 
was 40 ml/min throughout the experiment. IPRL were first perfused with 2.1 µM 
UB/3% BSA for 15 min, and then with 75 µM tBuOOH for 15 min. During the 
perfusion process, bile samples were collected for gravimetric assessment of bile flow 
(assuming a bile density of 1.0 g/ml)and for chemical determination of glutathione. In 
some experiments, taurocholate (2 µM) and CDNB (0.5 µM) were added to the 
perfusion buffer for further assessment of Bsep and Mrp2 function, respectively. The 
viability of the liver was monitored by the release of lactate dehydrogenase into the 
perfusate outflow; experiments exhibiting activities over 20 U/L were discarded. 
Basiglio et al 
 
12 
 
Assessment of oxidized glutathione:total glutathione relation in bile. Bile samples 
were subjected to assessment of both oxidized (GSSG) and total glutathione (GSHt) by 
the recycling method of Tietze (1969), as modified by Griffith (1980). The GSSG/GSHt 
relation in bile is a sensitive marker of hepatic OS (Lauterburg et al. 1984). 
Assessment of biliary secretion of bile salts anddinitrophenyl-glutathione (GS-DNP). 
Total bile salts were determined by the 3α-hydroxysteroid dehydrogenase procedure, as 
described by Talalay (1960). Biliary secretion of GS-DNP, a model Mrp2 substrate, was 
determined by HPLC.  
Localization studiesof Bsep, Mrp2 and F-actin. Confocal microscopy was used to 
visualize both internalization of Bsep and Mrp2 from the canalicular domain and 
organization of actin cytoskeleton. Briefly, liver samples, obtained 20 min after the 
onset of tBuOOH perfusion, were prepared with a Zeiss Microm HM500 microtome 
cryostat (Carl Zeiss LLC, Thornwood, NY, USA). For Bsep and Mrp2 labeling, tissue 
sections were incubated overnight with the specific antibody to Bsep (1:100) or to Mrp2 
(1:100). Sections were incubated either with Cy2-conjugated donkey anti-rabbit IgG 
(1:100) or with Cy2-conjugated goat anti-mouse IgG (1:100) and with Alexa Fluor 568 
phalloidin for F-actin staining for 1 h.  
Western blot analysis of PKCα activation.After culture for 24 h, isolated rat 
hepatocytes were exposed to tBuOOH (100 μM) for 15 min, washed with cold 0.3 M 
sucrose, resuspended in 0.3 M sucrose plus protease inhibitors (25 μg/mL leupeptin, 5 
μg/mL pepstatin A and 0.1 mM PMSF), and disrupted by sonication. In separate 
experiments, we tested the effect of UB (17.1 μM) by exposing the cells for 15 min to 
the pigment, previous to the incubation with tBuOOH (100 μM) for 15 min or its 
solvent. Cytosolic (supernatant) and total membrane (pellet)-enriched fractions were 
Basiglio et al 
 
13 
 
obtained by ultracentrifugation for 60 min at 100,000 × g (Carreras et al. 2003) and total 
protein determined (Lowry et al. 1951). Proteins were separated by electrophoresis on a 
12%-SDS-polyacrylamide gel and after electrotransfer, nitrocellulose membranes 
(Immobilon-P membranes) were incubated overnight with a mouse monoclonal 
antibody to PKCα (BD Biosciences Pharmingen; 1:1,000). Stripped membranes were 
reprobed with a mouse anti-β actin antibody (Sigma, 1:5,000, 1 h). After incubation 
with a donkey anti-mouse IgG secondary antibody (Thermo Fisher, 1:5000, 1h), a 
chemiluminescence reagent, and Hyperfilm ECL, PKCα and β actin bands were 
quantified by densitometry with ImageJ 1.44m (National Institutes of Health) software. 
To estimate the amount of PKCα associated with both cytosolic and membrane 
fractions, the relative intensity of each PKCα band was related to the correspondent β 
actin band, divided by the μg of protein loaded in that lane, and then multiplied by the 
total amount of protein recovered in the corresponding fraction. The proportion of 
membrane-bound PKCα was expressed as the amount in membranes relative to the total 
(membrane-bound + cytosolic) amount the protein.  
 
Statistical analysis. 
Results were expressed as mean ± S.E.M. When requirements for parametric 
analysis were met, a Student‟s unpaired t test was used for comparison between two 
groups; comparisons that did not meet this criterion were carried out using the Mann-
Whitney‟s rank sum test. The Kruskal-Wallis‟ test (one-way ANOVA by ranks) was 
used when more than two groups were compared, followed by the Dunn's multiple-
comparison, post hoc test for pairwise comparisons, if ANOVA reached any statistical 
significance among groups. pvalues lower than 0.05 were judged to be significant. The 
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variances of the densitometric profiles of Bsep and Mrp2 localization were compared 
with the Mann-Whitney U test. p values < 0.05 were considered to be statistically 
significant. 
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RESULTS 
 
Effect of UB on the oxidative damage induced by tBuOOH in isolated rat hepatocytes. 
Hepatocytes were incubated with or without UB (1.7-85 µM, 15 min) and then with 
tBuOOH (100 µM, 15 min). We found that concentrations of UB up to 42.5 µM fully 
prevented formation of malondialdehyde (MDA), while higher concentrations did not 
(Figure 1, panel a). This finding prompted us to continue studying the antioxidant 
capacity of UB using the physiological concentration of 17.1 µM. We found that ROS 
formation was completely prevented by UB (Figure 1, panel b). These results indicate 
acytoprotective action of UB on the pro-oxidant effects of tBuOOH. UB had no direct 
effect on basal oxidative status, since hepatocytes incubated only with UB showed 
similar levels of ROS and MDA content to control cells. 
 
Effect of UB on the impairment of function and localization of the canalicular 
transporters Bsep and Mrp2 induced by tBuOOH in IRHC.After incubation with UB 
(17.1 µM, 15 min) and tBuOOH (100 µM, 15 min), we evaluated the percentage of 
IRHC able to accumulate the fluorescent substrates CGamF or GS-MF in their 
canalicular vacuole. Control IRHC exposed only to BSA (UB vehicle) and DMSO 
(tBuOOH vehicle) showed a 55-60% accumulation of either fluorescent substrates. We 
found that, while tBuOOH caused a decrease in the percentage of couplets accumulating 
the fluorescent substrates in their vacuoles, UB fully prevented thisdecrease (Figure 2, 
panel a). 
To elucidate whether the functional impairment of canalicular transporters 
induced by tBuOOH was due to a relocalization of such transporters from the 
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canalicular membrane to submembraneous vesicles, we carried out localization studies 
by confocal microscopy followed by image analysis. In control IRHC, both Bsep and 
Mrp2 were mainly confined to the canalicular membrane, while tBuOOH (100 µM) 
induced relocalization of both transporters into vesicles localized all over the couplet 
body. Redistribution of Bsep and Mrp2 was fully andpartially prevented by UB (17.1 
µM), respectively. UB did not have any independent effect on localization of these 
transporters (Figure 2, panel b).  
 
Effect of UB on bleb formation and F-actin redistribution induced by tBuOOH. To 
assess whether endocytic internalization of Bsep and Mrp2 was due to actin 
cytoskeleton disarrangement, bleb formation was assessed as a preliminary marker of 
actin cytoskeleton disruption (Gores et al. 1990). tBuOOH (100 µM) induced extensive 
plasma membrane blebbing (as visualized by phase-contrast microscopy), while UB 
(17.1 µM) almost fully prevented this event (Figure 3, panel a). F-actin distribution 
under the same conditions used to study Bsep and Mrp2 localization was also assessed 
(Figure 3, panel b). In control couplets, F-actin displayed pericanalicular localization, 
forming a dense belt around the canalicular membrane.tBuOOH induced extensive 
redistribution of F-actin from the pericanalicular area to both the cell body and the 
sinusoidal plasma membrane, particularly in the areas where blebs occurred. As with 
transporters localization and bleb formation, redistribution of F-actin was almost fully 
prevented by pretreatment of IRHC with UB. These findings strongly support the notion 
that UB prevents oxidative biliary secretory failure by preventing the canalicular 
transporters endocytosis that occurs as a consequence of actin cytoskeleton disruption. 
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Effect of UB on the oxidative damage induced by tBuOOH in IPRL.After isolation, 
livers were perfused first with UB (2.1 µM, 15 min) or its vehicle (3% BSA), and then 
with tBuOOH (75 µM, 15 min). Ancillary experiments aimed at setting the conditions 
for liver perfusion showed that 2.1 µM and 75 µM were the optimal concentrations of 
UB and tBuOOH in this model, respectively. Oxidative injury was evaluated by 
measuring the GSSG/GSHt relation in bile. Time variations in this parameter were 
expressed as percentages of the value obtained at t = 0 (onset of the perfusion process). 
While tBuOOH induced a sharp and transient increase in GSSG/GSHt relation, UB 
markedly attenuated this phenomenon (Figure 4, panel a). 
 
Effect of UB on bile flow impairment induced by tBuOOH. Bile flow sharply dropped 
after perfusion with tBuOOH, reaching a minimum at 20 min after the onset of the 
perfusion with the pro-oxidant agent. Pre-perfusion of IPRL with UB completely 
prevented the decrease in bile flow, so that its time course profile was similar to that of 
Control livers (Figure 4, panel b). UB per se did not cause any alterations in bile flow. 
 
Effect of UB on biliary secretion of Bsep and Mrp2 substrates. Since we found that 
bile flow was impaired by tBuOOH perfusion, we assessed whether Bsep and Mrp2 
function was also impaired. For this purpose, in another set of experiments, taurocholate 
and CDNB were added to the perfusion solution at the beginning of the perfusion 
process. Time variations in the excretion of either substrates were expressed as 
percentages of the values obtained at t = 0 (onset of the perfusion process). We found 
that tBuOOH (75 µM) induced a 70% decrease in the biliary excretion of taurocholate, a 
Bsep substrate, and that UB (2.1 µM) partially prevented this decrease (Figure 4, panel 
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c). Similarly, UB fully prevented the abrupt decrease in the biliary excretion of the 
Mrp2 substrate GS-DNP (Figure 4, panel d). Our results show that UB prevents the OS-
induced functional impairment of both Bsep and Mrp2, the two key canalicular 
transporters involved in bile secretion. 
 
Effect of UB on Bsep, Mrp2 and F-actin localization.Tissue sections obtained from 
IPRL experiments were subjected to specific co-staining of Bsep (green) and actin (red), 
or of Mrp2 (green) and actin (red). tBuOOH induced redistribution of both transporters 
from the canalicular membrane into vesicles located either in cytosol or around the 
pericanalicular area, as evidenced by an increase in colocalization of these transporters 
with pericanalicular actin (yellowish area). Aconcomitant disruption of actin 
cytoskeleton became also apparent, as shown by the distortion and discontinuity of the 
actin pericanalicular belt in the tBuOOH group, as compared with the control one. Pre-
perfusion with UB almost fully prevented all these alterations(Figure 5). Taken 
together, these results strongly suggest that the protective action of UB on the oxidative 
impairment of biliary secretory function is exerted at the level of actin cytoskeleton 
integrity, and its consequent role in the proper canalicular localization of transporters 
that are crucial to the biliary secretion process. 
 
Effect of UB on PKCα activation.Activation of PKCα, the main cPKC in hepatocytes, 
is associated with translocation of the protein from the cytosol to cellular membranes. 
Representative immunoblots of PKCα in both cytosolic and membrane fractions of 
primary cultured rat hepatocytes incubated with 100 µM tBuOOH , in the presence or 
absence of 17.1 µM UB, are shown in the upper panel of Figure 6. tBuOOH increased 
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membrane-bound (active) PKCα by 50%. This was fully prevented by pre-incubation of 
the cells with 17.1 μM UB (lower panel of Figure 6).  
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DISCUSSION 
Bilirubin, historically considered a waste product of heme catabolic pathway and 
even a potentially toxic compound, is nowadays regarded as a potent antioxidant agent 
(Sedlak et al. 2009, Stocker et al. 1987a, Vitek 2012). This study provides new insights 
into the hepatoprotective properties of UB by showing that the pigment, when present at 
physiological concentrations, can preserve the functional status of hepatocytes in terms 
of biliary secretory function under OS conditions, serving as a crucial antioxidant 
defense to keep the secretory machinery in operation after an oxidative challenge. 
We first tested the antioxidant effect of UB at physiological concentrations in a 
hepatocellular, in vitro model of oxidative-stress damage, as that induced by the model 
pro-oxidant agent tBuOOH to isolated hepatocytes; tBuOOH freely diffuses across the 
plasma membrane, and is converted into oxygen (peroxyl and alkoxyl) free radicals 
mainly by microsomal cytochrome P450 (Davies 1989) and, to a lesser extent, through 
reduction in the mitochondrial electron transport chain (O´Donnel and Burkitt 1994). 
We found that tBuOOH increased ROS formation in this model and that physiological 
concentrations of UB completely prevented this effect. 
A possible mechanism underlying UB antioxidant action likelyinvolves the cycle 
between bilirubin and biliverdin catalyzed by the enzyme biliverdin reductase, which 
would allow a single bilirubin molecule to function as an antioxidant many times 
over(Sedlak and Snyder 2004, Liu et al. 2006). Indeed, the tissue concentrations of UB 
(~ 20-50 nM) are by far too low to cope with the mM levels of ROS that cells encounter 
physiologically, but due to the biliverdin-UB cycle, as little as 10 nM UB protects 
against 10,000 higher fold concentrations of hydrogen peroxide(Doré et al. 
1999).However, other authors have found that bilirubin oxidation yields little, if any, 
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biliverdin (McDonagh 2010, Maghzal et al. 2009), thus favoring the hypothesis that 
bilirubin may simply act as a scavenger of ROS by blocking the initiation of a radical 
chain process (Stocker 2004). This may be particularly so in our cellular/tissular 
systems.In IRHC and IPRL experiments, UB was added to the incubation/perfusion 
solution in a 1:1 molar ratio with human serum albumin, but once inside the 
hepatocytes, UB bounds to the cytosolic organic anion-binding protein, glutathione 
transferase. Maghzal et al. demonstrated that, in a model of extracellular (albumin-
bound) bilirubin, oxidative conversion to biliverdin after an oxidative challenge is very 
efficient, but oxidation of glutathione transferase-bound bilirubin yields only modest 
amounts of biliverdin (2009). 
The link between the well-recognized capability of UB to scavenge ROS in non-
cellular systems should not be extrapolated mechanically to isolated hepatocytes, or to 
the situation in vivo. Indeed, in a cellular-preserved context, UB has dual, antioxidant 
and pro-oxidant effects depending on its exposure levels. This is in line with our results 
showing that only physiological (i.e., up to 17.1 µM) UB concentrations significantly 
prevented tBuOOH-induced lipid peroxidation, without further improvements at twice 
higher concentrations of the pigment, and loss of the protective effect at four-time 
higher concentrations (see Figure 1 a). Protective effects of physiological UB levels 
against OS-induced hepatocellular damage are consistent with those recently published 
by Zelenka et al.(2012), who found that intracellular accumulation of UB derived from 
sodium arsenite-induced increase in heme production and further HO-1 induction is 
associated with a dramatic decrease in lipid peroxidation in HepG2 cells. On the other 
hand, potential deleterious effects of higher levels of bilirubin is illustrated by the 
finding that up-regulation of HO-1 in rats subjected to either bile duct ligation (Froh 
Basiglio et al 
 
22 
 
etal. 2007) or Cl4C exposure (Eipel et al. 2007), two maneuvers inducing ROS-mediated 
hepatocellular damage, increase rather than attenuate liver injury, an effect that was 
prevented by HO-1 inhibitors. 
The finding that UB, at low levels, i.e. with such a high efficiency, is 
instrumental in preventing OS in hepatocytes, led us to speculate that physiological 
concentrations of bilirubin may protect hepatocanalicular secretory function from an 
oxidative challenge. If so, the finding may have implications to explain the paradoxical 
findings often described in the literature that, despite most liver diseases involve either 
or both high ROS production and impairment of antioxidant defenses, they are often 
non-cholestatic in nature. For example, viral hepatitis is characterized by OS generation 
due to a combination of chronic inflammation, iron overload, mitochondrial damage, 
and proteins encoded by the virus (Stehbens 2004, Choi and Ou 2006). However, few 
cases occur with overt cholestasis (e.g. 2% in viral hepatitis A) (Petrov et al. 2012), and 
the incidence is even lower in viral hepatitis B and C (Davies et al. 1991). Another 
example is non-alcoholic fatty liver disease. Even when OS is critically involved in both 
onset and progression of the disease (Rolo et al. 2012), histological images reveal that 
the few patients displaying cholestatic features have ductular rather than hepatocellular 
damage (Sorrentino et al. 2005). The discrepancy between the relatively low cholestatic 
impact of OS in clinical hepatopathies and the well-established evidence that OS is 
highly cholestatic when studied in in vitro models (e.g. IRHC, HepG2 cell line, IPRL) 
may be due to the absence of extracellular UB in the latter experimental settings. 
Therefore, UB may be crucial to preserve ongoing bile secretion despite extensive 
occurrence of pro-oxidant mechanisms in liver disease. 
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A key event leading to hepatocanalicular dysfunction under OS conditions is the 
disarrangement of the F-actin cytoskeleton. This structure is mainly localized in 
hepatocytes around the canalicular membrane, and critically influences transporter 
stability in this membrane domain. Actin can interact with, and possibly regulate, 
transmembrane proteins via binding to radixin, which acts as a cross-linker between 
canalicular transporters and actin filaments (Crocenzi et al. 2012). In line with this, the 
actin-cytoskeleton disrupting agent phalloidin triggers rapid internalization of Mrp2 
(Rost et al. 1999), and mice lacking radixin develop conjugated hyperbilirubinemia 
associated with Mrp2 retrieval(Kikuchi et al. 2002). We have previously shown that the 
OS-mediated cytosolic Ca
2+
 increase and the further activation of cPKC are involved in 
F-actin disarrangement, rather than direct oxidation of actin sulfhydryl groups (Pérez et  
al. 2006a,b). Here, we demonstrated that UB helps to preserve F-actin integrity by 
hampering OS-mediated cPKC activation, because of its scavenging properties. 
UB is highly lipophilic, and therefore it preferentially protects cell membranes, 
including the mitochondrial ones, from lipid peroxidation (Sedlak et al. 2009); UB is 
even more efficient than α-tocopherol, which is regarded as the best exogenous 
antioxidant against lipid peroxidation (Stocker et al. 1987a, Mancuso et al. 2012). Low 
OS levels, like those developed under our experimental conditions, selectively impair 
mitochondrial function. At the concentrations used here, tBuOOH was shown to cause 
mitochondrial pyridine nucleotide oxidation, which disrupts the balance of 
mitochondrial Ca
2+
 uptake and release, leading to a net increase of mitochondrial Ca
2+
; 
the combination of increased Ca
2+
 and ROS levels causes opening of the mitochondrial 
permeability transition pores, which induces further OS and mitochondrial Ca
2+
 uptake 
(Byrne et al. 1999). Eventually, this opens ATP-sensitive, non-specific cation channels, 
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thus leading to Ca
2+
 influx from the extracellular medium (Sato et al. 2009). 
Additionally, tBuOOH-derived ROSmay induce direct activation of the reverse mode of 
the plasma membrane carrier, Na
+
/Ca
2+
 exchanger(Kim et al. 2000). It is therefore 
tempting to speculate that bilirubin is the „„first line of defense‟‟ to hamper these 
membrane-based processes, by preventing both mitochondria dysfunction and oxidation 
of plasma membrane-integrated carriers, thus preventing the cytosolic Ca
2+
 rise and the 
further cPKC activation. Actually, we showed here that UB is indeed able to prevent 
activation of this harmful, pro-cholestatic signaling pathway. 
Even when bilirubin can efficiently counteract the cascade of events involved in 
OS-induced hepatocanalicular dysfunction, actual protection against cholestasis induced 
by OS needs to be confirmed, as we did here. Indeed, the anticholestatic effects of UB 
may be limited by direct, deleterious effects of the pigment on the functional status of 
canalicular transporters. Large loads of UB to experimental animals induce cholestasis, 
due to a marked impairment of Bsep activity by direct perturbations on the plasma 
membrane environment (Labori et al. 2002). Our finding that UB restored to normality 
not only the localization status but the functional activity of both Bsep and Mrp2, as 
shown both in the IRHC and the IPRL models using specific substrates (see Figures 2 
and 4, respectively), indicates that the levels of UB required to afford protection against 
a cholestatic oxidant challenge are not harmful but protective to biliary secretory 
function. 
There is developing evidence in the literature that UB can counteract oxidative-
stress mediated cholestasis, although their putative beneficial effects are related to late 
improvements in canalicular transporters expression rather than prevention of acute 
changes in localization, as demonstrated here. The evidence is also indirect, since it 
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relays on manipulation of UB hepatocellular levels by modulation of HO-1 activity. For 
example, pre-induction of HO-1 with a hemoglobin analogue ameliorated cholestasis 
and downregulation of Bsep and Mrp2 in cholestasis induced by cold ischemia-
reperfusion of rat liver, an OS-related injury (Granato et al. 2003); however, other 
products derived from the HO-1-catalyzed reaction, e.g. CO, may have accounted for  
this protection. Our results showing conclusively that direct exposure to UB counteracts 
the cholestatic effects of OS help to support the contention that changes in HO-1 
activity under cholestaticconditions, considered rather as an epiphenomenon in the 
context of the disease, may be a key protective mechanism as a source of protective, 
anticholestatic UB. Interestingly, bile salts, which are retained in cholestasis due to the 
biliary secretory failure, have been shown to upregulate HO-1(Donner et al. 2012), and 
cholestasis is associated with an enlargement of the free cytosolic pool of the HO-1 
substrate heme (González et al.2011). It is therefore tempting to speculate that bile salts 
favor the production of an antioxidant (UB) against its own pro-oxidant effects when 
retained during a cholestatic process; this may attenuate the progression of the disease 
by breaking the vicious circle in which bile salts retained by the cholestatic process 
induce OS, which in turn induces more cholestasis. Furthermore, since expression of 
HO-1 is rapidly upregulated in the liver following any oxidative challenge, HO-1 
induction may represent an adaptive response to mitigate the severity of the oxidative 
damage (Schacter et al. 1983), including the cholestatic one.  
In conclusion, the data presented here demonstrate that physiological 
concentrations of UB prevent oxidative-stress induced hepatocellular damage. This 
cytoprotective effect is exerted through prevention of actin cytoskeleton disarrangement 
and the consequent endocytic internalization of canalicular transporters crucial to biliary 
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secretory function. These findings support the notion that an endogenously generated 
metabolite, UB, may act as an efficient antioxidant agent at physiological (micromolar) 
concentrations.Whatever the molecular mechanism of UB antioxidant action is, it is 
clear from the data presented here that the pigment can neutralize ROS that are 
continuously being generated as a consequence of hepatocellular metabolic activity, and 
that this antioxidant effect may become highly relevant to preserve normal biliary 
function. Furthermore, since ROS become often increased in liver under a myriad of 
pathological conditions, and since UB often accumulates in tissues and plasma in these 
hepatopathies, we hypothesize that those hepatic diseases bearing an oxidative 
background would have a worse outcome in terms of hepatobiliary function in the 
absence of UB. This encourages further characterization of the therapeutic potential of 
UB manipulation in liver disease. 
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FIGURE LEGENDS  
Fig 1Protective effect of unconjugated bilirubin (UB) on the oxidative damage 
induced by tert-butylhydroperoxide(tBuOOH) in isolated rat hepatocytesa) Lipid 
peroxidation levels.Hepatocytes were incubated in the presence or absence of UB (1.7 – 
85 µM), for 15 min. Then, tBuOOH (100 µM) was added to the incubation medium, 
and cells were incubated for another 15-min period. Lipid peroxidation was evaluated 
by the generation of malondialdehyde (MDA), as assessed by HPLC. We found that 
concentrations of UB up to 42.5 µM prevented MDA formation. Data are expressed as 
mean ± S.E.M. 
a
Significantly different from Control. 
b
Significantly different from 
tBuOOH (p< 0.05; n = 4). b) Intracellular ROS production, assessed by measuring the 
oxidant-sensitive intracellular production of 2′,7′-dichlorofluorescein from its non-
fluorescent, freely diffusible precursor 2′,7′- dichlorofluorescin diacetate, by 
fluorimetric detection. Hepatocytes preloaded with the probe were incubated with or 
without UB (17.1 µM, 15 min), and then with tBuOOH (100 µM, 15 min). Data are 
expressed as mean ± S.E.M. 
a
Significantly different from Control. 
b
Significantly 
different from tBuOOH (p< 0.05; n = 4) 
 
Fig 2Protective effect of unconjugated bilirubin (UB) on the altered function and 
localization of canalicular transporters induced by tert-butylhydroperoxide(tBuOOH) 
in isolated rat hepatocytes couplets (IRHC) Couplets were incubated in the presence or 
absence of UB (17.1 µM, 15 min), and then in the presence of tBuOOH (100 µM, 15 
min). After this treatment, we tested: a) Percentage of IRHC (referred to control values) 
able to accumulate the fluorescent Bsep and Mrp2 substrates, cholyl-glycylamido-
fluorescein (CGamF) and glutathione-methylfluorescein (GS-MF), respectively, into 
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their canalicular vacuoles. The results are expressed as percentages of the control group, 
and are shown as mean ± S.E.M. 
a
Significantly different from Control. 
b
Significantly 
different from tBuOOH (p< 0.05; n = 5). b) Changes in localization of Bsep (left panel) 
and Mrp2 (right panel), as illustrated by representative confocal immunofluorescence 
images. Changes in transporter localization were quantified by densitometric analysis of 
the fluorescence intensity along a line (8 μm), perpendicular to the center of the 
canalicular vacuole (from +4 to -4 μm). Representative confocal immunofluorescence 
images of the localization of Bsep and Mrp2 are also shown. Note that, in control 
IRHC, both Bsep- and Mrp2-associated fluorescence was localized mainly within the 
canalicular vacuole, whereas in the group treated with tBuOOH alone, there was 
extensive relocalization of the fluorescence from the canalicular zone to the cellular 
body, thus indicating endocytosis of these canalicular carriers. Statistical analysis of the 
fluorescence profiles showed a significant change in the IRHC treated with tBuOOH 
(p< 0.05; number of analyzed canalicular vacuoles > 10), and this phenomenon was 
prevented by UB pretreatment for both Bsep and Mrp2 
 
Fig 3Effect of unconjugated bilirubin (UB) on the disruption of actin cytoskeleton 
induced bytert-butylhydroperoxide (tBuOOH) in isolated rat hepatocyte couplets 
(IRHC) Couplets were isolated and incubated in the presence or absence of UB (17.1 
µM, 15 min), and then exposed totBuOOH (100 µM, 15 min). At the end of the 
experiments, changes in actin localization were evaluated by (a) bleb formation, as 
assessed by phase-contrast microscopy, and (b) actin staining with fluorescently-labeled 
phalloidin; canalicular localization of actin was then quantified by assessing the 
proportion of fluorescence intensity localized in the pericanalicular zone. Data are 
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expressed as mean ± S.E.M. 
a
Significantly different from Control. 
b
Significantly 
different from tBuOOH (p< 0.05; n = 4) 
 
Fig 4Effect of unconjugated bilirubin (UB) on the alterations in biliary secretory 
function induced by tert-butylhydroperoxide (tBuOOH) in the isolated perfused rat 
liver (IPRL) After a 20-min equilibration period, UB (or its vehicle, 3% BSA, in 
Control and tBuOOH alone groups) was added to the reservoir so as to reach a 2.1 µM 
final concentration. Fifteen min after UB addition, a 10-min bile sample was collected, 
followed by a shift of the perfusion medium to another one containing 75 µM tBuOOH 
(or DMSO in Control and UB alone groups) or 75 µM tBuOOH + 2.1 µM UB. After a 
15-min perfusion with tBuOOH or tBuOOH + UB, the perfusion medium was shifted 
back to the basal medium, containing neither UB nor tBuOOH. Bile samples were 
collected at 10-min intervals for 60 min. Temporal changes of the following parameters 
(expressed as percentages of their mean basal values recorded at the onset of the 
perfusion process) were assessed, namely: a) the ratio of oxidized glutathione (as 
glutathione disulfide, GSSG) tototal (reduced + oxidized) glutathione (GSHt); b) bile 
flow; c) biliary excretion of bile salts, resulting from having added a traceable dose of 
the Bsep substrate taurocholate to the perfusion medium; d) biliary excretion of the 
Mrp2 substrate dinitrophenyl-glutathione (GS-DNP) resulting from having added 
chloro-dinitrobenzene (CDNB) to the perfusion medium. Note that UB markedly 
prevented the abrupt increase in the GSSG/GSHt relation, the drop in bile flow, and the 
decrease in the excretion of both bile salts and GS-DNP induced by tBuOOH. Data are 
expressed as mean ± S.E.M. *Significantly different from Control, UB and 
UB+tBuOOH (p< 0.05, n = 5) 
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Fig 5Endocytic internalization of Bsep and Mrp2 and disruption of F-actin 
cytoskeleton induced by tert-butylhydroperoxide (tBuOOH), and their prevention by 
unconjugated bilirubin (UB) in isolated perfused rat liver 
(IPRL)Representativeconfocal images illustrating the endocytic internalization of Bsep 
and Mrp2 induced by tBuOOH, and its prevention by UB. The images were taken from 
IPRL samples, excised 20 min after the onset of tBuOOH perfusion. a)Co-staining of 
Bsep (green) and F-actin (red); b)Co-staining of Mrp2 (green) and F-actin (red). In both 
sets of micrographs, the following groups are shown: A) Control (vehicles only), B) UB 
(2.1 µM, 15 min), C)tBuOOH (75 µM, 10 min), D) UB (2.1 µM, 15 min)+tBuOOH (75 
µM, 10 min). Note that, in control livers, both Bsep and Mrp2 were mainly confined to 
the canalicular space, while in livers treated with tBuOOH, relocalization of both Bsep 
and Mrp2 from the canalicular space to the pericanalicular area became apparent, thus 
suggesting endocytic internalization of the transporters. UB prevented this phenomenon, 
as illustrated by a control-like pattern of Bsep and Mrp2 distribution in livers pre-treated 
with UB. Note also that pericanalicular localization of F-actin was only apparent in 
control livers, while a severe disarrangement of F-actin was observed in livers perfused 
with tBuOOH. UB partially prevented the oxidative stress-induced disruption on F-actin 
localization, thus explaining the protective effects of UBon canalicular transporters 
localization and function 
 
Fig 6Effect of unconjugated bilirubin (UB) on protein kinase C (PKC) activation by 
tert-butylhydroperoxide (tBuOOH) The upper panels are representative western blots 
of membrane PKC and cytosolic PKC obtained from whole cellular lysates of isolated 
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rat hepatocytes incubated with tBuOOH (100 lM) for 15 min or with tBuOOH (100 lM) 
for 15 min in cells pretreated with UB for 15 min. The lower panel shows the PKC 
activation status (expressed as the membrane-localized PKC to total PKC ratio) for each 
experimental condition. An arbitrary value of 100 was assigned to the band of highest 
densitometric intensity in every western blot before the membrane-localized PKC to 
total PKC ratio was calculated. Data are expressed as mean ± S.E.M. 
a
Significantly 
different from Control. 
b
Significantly different from tBuOOH (p< 0.05; n = 4) 
